middle.news
AdAlta Accelerates 'East to West' Strategy with Three CAR-T Assets in Pipeline
9:08am on Thursday 6th of February, 2025 AEDT
•
Biotechnology
Read Story
AdAlta Accelerates 'East to West' Strategy with Three CAR-T Assets in Pipeline
9:08am on Thursday 6th of February, 2025 AEDT
Key Points
AdAlta prioritizes 'East to West' cellular immunotherapy strategy for solid cancers
Two new non-binding term sheets signed, totaling three assets in advanced due diligence
Focus shifts from internal R&D on AD-214 to external partnerships and licensing
Strategy leverages Asian innovation to access Western regulated markets
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE